Scientific Opinion on the substantiation of health claims related to coenzyme Q10 and contribution to normal energy-yielding metabolism (ID 1508, 1512, 1720, 1912, 4668), maintenance of normal blood pressure (ID 1509, 1721, 1911), protection of DNA, proteins and lipids from oxidative damage (ID 1510), contribution to normal cognitive function (ID 1511), maintenance of normal blood cholesterol concentrations (ID 1721) and increase in endurance capacity and/or endurance performance (ID 1913) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

EFSA Journal

Volumn 8, Issue 10, 2010, Pages

[No Author Info available]

Author keywords

blood pressure; cholesterol; Coenzyme Q10; cognitive function; endurance; energy yielding metabolism; health claims; oxidative damage

Indexed keywords

EID: 85078377257     PISSN: None     EISSN: 18314732     Source Type: Journal    
DOI: 10.2903/j.efsa.2010.1793     Document Type: Article

References (35)

1. Alleva R, Tomasetti M, Battino M, Curatola G, Littarru GP and Folkers K, 1995. The roles of coenzyme Q10 and vitamin E on the peroxidation of human low density lipoprotein subfractions. Proceedings of the National Academy of Sciences, 92, 9388–9391.
2. Burke BE, Neuenschwander R and Olson RD, 2001. Randomized, double-blind, placebo-controlled trial of coenzyme Q10 in isolated systolic hypertension. Southern Medical Journal, 94, 1112–1117.
3. Cerioli G, Tirelli F and Mustani L, 1991. Effect of CoQ10 on the metabolic response to work. Biomedical and Clinical Aspects of Coenzyme Q, 6, 521–524.
4. Chew GT, Watts GF, Davis TM, Stuckey BG, Beilin LJ, Thompson PL, Burke V and Currie PJ, 2008. Hemodynamic effects of fenofibrate and coenzyme Q10 in type 2 diabetic subjects with left ventricular diastolic dysfunction. Diabetes Care, 31, 1502–9.
5. Digiesi V, Cantini F and Brodbeck B, 1990. Effect of coenzyme Q10 on essential arterial hypertension. Current Therapeutic Research, 47, 841–845.
6. Griffiths HR, Moller L, Bartosz G, Bast A, Bertoni-Freddari C, Collins A, Cooke M, Coolen S, Haenen G et al., 2002. Biomarkers Molecular Aspects of Medicine, 23, 101–208.
7. Gutzmann H, Kuhl KP, Hadler D and Rapp MA, 2002. Safety and efficacy of idebenone versus tacrine in patients with Alzheimer's disease: results of a randomized, double-blind, parallel-group multicenter study. Pharmacopsychiatry, 35, 12–18.
8. Hodgson JM, Watts GF, Playford DA, Burke V and Croft KD, 2002. Coenzyme Q10 improves blood pressure and glycaemic control: a controlled trial in subjects with type 2 diabetes. European Journal of Clinical Nutrition, 56, 1137–1142.
9. IoM (Institute of Medicine), 2005. Dietary reference intakes for vitamines and minerals. National Academies Press, Washington D.C.
10. Kaikkonen J, Tuomainen TP, Nyyssonen K and Salonen JT, 2002. Coenzyme Q10: absorption, antioxidative properties, determinants, and plasma levels. Free Radic Research, 36, 389–397.
11. Knasmüller S, Nersesyan A, Misik M, Gerner C, Mikulits W, Ehrlich V, Hoelzl C, Szakmary A and Wagner KH, 2008. Use of conventional and -omics based methods for health claims of dietary antioxidants: a critical overview. British Journal of Nutrition, 99 E Suppl 1, ES3–52.
12. Kontush A, Hubner C, Finckh B, Kohlschutter A and Beisiegel U, 1994. Low density lipoprotein oxidizability by copper correlates to its initial ubiquinol-10 and polyunsaturated fatty acid content. FEBS Letters, 341, 69–73.
13. Lenaz G, Fato R, Castelluccio C, Cavazzoni M, Estornell E, Huertas JF, Pallotti F, Parenti Castelli G and Rauchova H, 1994. An updating of the biochemical function of coenzyme Q in mitochondria. Molecular Aspects of Medicine, 15 Suppl, S29–36.
14. Lenaz G, Parenti Castelli G, Fato, D'Aurelio M, Bovina C, Formiggini G, Marchetti M, Estornell E and Rauchova H, 1997. Coenzyme Q deficiency in mitochondria: kinetic saturation versus physical saturation. Molecular Aspects of Medicine, 18 Suppl, S25–31.
15. Linnane AW, Zhang C, Yarovaya N, Kopsidas G, Kovalenko S, Papakostopoulos P, Eastwood H, Graves S and Richardson M, 2002. Human aging and global function of coenzyme Q10. Annals of the New York Academy of Sciences, 959, 396–411.
16. Lykkesfeldt J, 2007. Malondialdehyde as biomarker of oxidative damage to lipids caused by smoking. Clinica Chimica Acta, 380, 50–58.
17. McDonald SR, Sohal RS and Forster MJ, 2005. Concurrent administration of coenzyme Q10 and alpha-tocopherol improves learning in aged mice. Free Radical Biology and Medicine, 38, 729–736.
18. Mizuno M, Quistorff B, Theorell H, Theorell M and Chance B, 1997. Effects of oral supplementation of coenzyme Q10 on 31P-NMR detected skeletal muscle energy metabolism in middle-aged post-polio subjects and normal volunteers. Molecular Aspects of Medicine, 18 Suppl, S291–298.
19. Mohr D, Bowry VW and Stocker R, 1992. Dietary supplementation with coenzyme Q10 results in increased levels of ubiquinol-10 within circulating lipoproteins and increased resistance of human low-density lipoprotein to the initiation of lipid peroxidation. Biochimica and Biophysica Acta, 1126, 247–254.
20. Quiles JL, Ochoa JJ, Huertas JR, Mataix J, 2004. Coenzyme Q supplementation protects from age-related DNA double-strand breaks and increases lifespan in rats fed on a PUFA-rich diet. Experimental Gerontology, 39, 189–194.
21. Quiles JL, Ochoa JJ, Battino M, Gutierrez-Rios P, Nepomuceno EA, Frias ML, Huertas JR, Mataix J, 2005. Life-long supplementation with a low dosage of coenzyme Q10 in the rat: effects on antioxidant status and DNA damage. Biofactors, 25, 73–86.
22. Rosenfeldt F, Hilton D, Pepe S and Krum H, 2003. Systematic review of effect of coenzyme Q10 in physical exercise, hypertension and heart failure. Biofactors, 18, 91–100.
23. Rosenfeldt FL, Haas SJ, Krum H, Hadj A, Ng K, Leong JY and Watts GF, 2007. Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials. Journal of Human Hypertension, 21, 297–306.
24. st Series) on nutrient and energy intakes for the European Community. Office for Official Publications of the European Communities, Luxembourg.
25. Shults CW, Oakes D, Kieburtz K, Beal MF, Haas R, Plumb S, Juncos JL, Nutt J, Shoulson I, Carter J, Kompoliti K, Perlmutter JS, Reich S, Stern M, Watts RL, Kurlan R, Molho E, Harrison M and Lew M, 2002. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Archives of Neurology, 59, 1541–1550.
26. Singh RB, Niaz MA, Rastogi SS, Shukla PK and Thakur AS, 1999. Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease, Journal of Human Hypertension, 13, 203–208.
27. Singh RB, Niaz MA, Kumar A, Sindberg CD, Moesgaard S and Littarru GP, 2005. Effect on absorption and oxidative stress of different oral Coenzyme Q10 dosages and intake strategy in healthy men. Biofactors, 25, 219–224.
28. Stocker R, Bowry VW and Frei B, 1991. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol. Proceedings of the National Academy of Sciences, 88, 1646–1650.
29. Tomasetti M, Littarru GP, Stocker R and Alleva R, 1999. Coenzyme Q10 enrichment decreases oxidative DNA damage in human lymphocytes. Free Radical Biology and Medicine, 27, 1027–1032.
30. Tran MT, Mitchell TM, Kennedy DT and Giles JT, 2001. Role of coenzyme Q10 in chronic heart failure, angina, and hypertension. Pharmacotherapy, 21, 797–806.
31. Weber C, Sejersgard Jakobsen T, Mortensen SA, Paulsen G and Holmer G, 1994. Antioxidative effect of dietary coenzyme Q10 in human blood plasma. International Journal for Vitamin and Nutrition Research, 64, 311–315.
32. Yamagami T, Takagi M, Akagami H, Kubo H, Toyama S, Okamoto T, Kishi T and Folkers K, 1986. Effect of coenzyme Q10 on essential hypertension: a double-blind controlled study. Biomedical and Clinical Aspects of Coenzyme Q, 5, 337–343.
33. Yamabe H and Fukuzaki H, 1991. The beneficial effect of coenzyme Q10 on the impaired aerobic function in middle aged women without organic disease. Biomedical and Clinical Aspects of Coenzyme Q, 535–540.
34. Young AJ, Johnson S, Steffens DC and Doraiswamy PM, 2007. Coenzyme Q10: a review of its promise as a neuroprotectant. CNS Spectrums, 12, 62–68.
35. Zeppilli P, Merlino B, de Lucca A and Littaru GP, 1991. Influence of CoQ10 on physical work capacity of athletes, sedentary people and patients with mitochondrial disease. Biomedical and Clinical Aspects of Coenzyme Q, 6, 541–545.